Back to Stakeholders

VA Connecticut Healthcare System

4 Trials

The VA Connecticut Healthcare System provides comprehensive medical and mental health services to veterans across Connecticut, with campuses in West Haven and Newington. As part of the VA's expanding psychedelic research program, it participates in clinical trials investigating MDMA-assisted therapy and psilocybin for PTSD and related conditions affecting veterans.

Quick Facts

Type: government
Website: Visit

Sponsored Trials

2

Open Label Ketamine Treatment for Major Depressive Disorder in Veterans

Start Date: January 31, 2017
Compounds: Ketamine

Naltrexone Plus Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder

Start Date: January 5, 2016
Compounds: Ketamine

Collaborated Trials

2

The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects

Start Date: April 3, 2023
Compounds: Ketamine, Placebo

Ketamine for Depression and Alcohol Dependence

Start Date: March 1, 2021
Compounds: Ketamine